AHR and cancer: In addition to binding AhR in cancer cells, secreted KYN can bind to AhR in immune cells, resulting in the functional attenuation of cytotoxic T cells and expansion of regulatory T cells, to facilitate an immunosuppressive microenvironment (14–16).